Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (Q40338985)
Jump to navigation
Jump to search
scientific article published on December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients |
scientific article published on December 2005 |
Statements
1 reference
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (English)
1 reference
Zora Modrusan
1 reference
Robert L Yauch
1 reference
Thomas Januario
1 reference
David A Eberhard
1 reference
Guy Cavet
1 reference
Wenjing Zhu
1 reference
Ling Fu
1 reference
Thinh Q Pham
1 reference
Robert Soriano
1 reference
Jeremy Stinson
1 reference
Somasekar Seshagiri
1 reference
Chin-Yu Lin
1 reference
Vincent O'Neill
1 reference
Lukas C Amler
1 reference
1 December 2005
1 reference
1 reference
11
1 reference
24 Pt 1
1 reference
8686-8698
1 reference
Identifiers
1 reference
1 reference